Noveris Health Sciences is trading 6.7% up at CA$0.08, with no clear catalyst identified.
- No company-specific announcement clearly linked to the October 7, 2026 move surfaced; the latest company news found was the September 9 annual-meeting results announcement.
- Biotech sentiment was under pressure and broader markets were lower, but neither explains the gain; the move appears unexplained by available news.